| Primary |
| Breast Cancer |
47.8% |
| Product Used For Unknown Indication |
10.4% |
| Gastric Cancer |
8.3% |
| Hepatic Neoplasm Malignant |
5.0% |
| Rhabdomyosarcoma |
3.6% |
| Breast Cancer Metastatic |
3.0% |
| Drug Use For Unknown Indication |
2.2% |
| Schizophrenia |
2.2% |
| Breast Cancer Female |
1.9% |
| Hypertension |
1.9% |
| Leiomyosarcoma |
1.5% |
| Non-hodgkin's Lymphoma Stage Iv |
1.5% |
| Vomiting |
1.5% |
| Bladder Cancer |
1.4% |
| Diffuse Large B-cell Lymphoma |
1.4% |
| Insomnia |
1.4% |
| Invasive Ductal Breast Carcinoma |
1.4% |
| Non-hodgkin's Lymphoma |
1.4% |
| Oesophageal Adenocarcinoma |
1.4% |
| Invasive Lobular Breast Carcinoma |
1.2% |
|
| Vomiting |
15.6% |
| Neutropenia |
9.7% |
| White Blood Cell Count Decreased |
9.7% |
| Liver Abscess |
8.4% |
| Pyrexia |
7.8% |
| Interstitial Lung Disease |
4.5% |
| Ischaemic Stroke |
4.5% |
| Thyroid Cancer |
4.5% |
| Thrombocytopenia |
3.9% |
| Febrile Neutropenia |
3.2% |
| Local Swelling |
3.2% |
| Rash |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Acute Myeloid Leukaemia |
2.6% |
| Asthenia |
2.6% |
| Myocardial Infarction |
2.6% |
| Pain In Extremity |
2.6% |
| Pneumonia |
2.6% |
| Renal Impairment |
2.6% |
| Ventricular Extrasystoles |
2.6% |
|
| Secondary |
| Breast Cancer |
57.3% |
| Gastric Cancer |
9.8% |
| Drug Use For Unknown Indication |
7.3% |
| Product Used For Unknown Indication |
5.5% |
| Breast Cancer Metastatic |
4.2% |
| Chemotherapy |
1.9% |
| Non-hodgkin's Lymphoma |
1.8% |
| Rhabdomyosarcoma |
1.5% |
| Acute Lymphocytic Leukaemia |
1.2% |
| Nausea |
1.2% |
| Metastatic Gastric Cancer |
1.1% |
| Oesophageal Carcinoma |
1.0% |
| Her-2 Positive Breast Cancer |
1.0% |
| B-cell Lymphoma |
0.8% |
| Diffuse Large B-cell Lymphoma |
0.8% |
| Gastrooesophageal Cancer |
0.8% |
| Malignant Breast Neoplasm |
0.7% |
| Prophylaxis |
0.7% |
| Premedication |
0.7% |
| Oesophageal Adenocarcinoma |
0.6% |
|
| Vomiting |
12.8% |
| Neutropenia |
11.4% |
| Pyrexia |
11.0% |
| Febrile Neutropenia |
7.9% |
| Thrombocytopenia |
7.0% |
| Pulmonary Embolism |
6.5% |
| Neutropenic Sepsis |
5.6% |
| Myocarditis |
4.7% |
| General Physical Health Deterioration |
4.3% |
| Acute Myeloid Leukaemia |
3.3% |
| Stomatitis |
3.0% |
| White Blood Cell Count Decreased |
2.9% |
| Dyspnoea |
2.8% |
| Disease Progression |
2.7% |
| Oesophagitis |
2.7% |
| Sepsis |
2.7% |
| Weight Decreased |
2.3% |
| Death |
2.2% |
| Mucosal Inflammation |
2.1% |
| Nausea |
2.1% |
|
| Concomitant |
| Breast Cancer |
41.1% |
| Chemotherapy |
10.9% |
| Drug Use For Unknown Indication |
7.7% |
| Breast Cancer Metastatic |
5.6% |
| Metastases To Bone |
5.5% |
| Product Used For Unknown Indication |
5.4% |
| Gastrooesophageal Cancer |
5.1% |
| Gastric Cancer |
3.9% |
| Prophylaxis |
2.1% |
| Premedication |
1.8% |
| Antiemetic Supportive Care |
1.5% |
| Hypertension |
1.4% |
| Oesophageal Adenocarcinoma |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Lymphoma |
1.1% |
| Gastric Cancer Stage Iv |
1.0% |
| Breast Cancer Female |
1.0% |
| Diffuse Large B-cell Lymphoma Stage Ii |
0.9% |
| Oesophageal Carcinoma |
0.9% |
| Ovarian Cancer |
0.9% |
|
| Neutropenia |
13.1% |
| Febrile Neutropenia |
9.0% |
| Pyrexia |
9.0% |
| Vomiting |
8.8% |
| Tooth Extraction |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Neutropenic Sepsis |
4.6% |
| Osteonecrosis |
4.4% |
| Pulmonary Embolism |
4.4% |
| Diarrhoea |
4.2% |
| Infection |
4.2% |
| Nausea |
3.9% |
| Stomatitis |
3.7% |
| Osteonecrosis Of Jaw |
3.3% |
| Weight Decreased |
3.3% |
| Disease Progression |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Drug Ineffective |
2.8% |
| Leukocytosis |
2.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.8% |
|
| Interacting |
| Gastric Cancer |
39.1% |
| Breast Cancer |
17.4% |
| Adenocarcinoma Gastric |
13.0% |
| Mental Disorder |
13.0% |
| Premedication |
8.7% |
| Depression |
4.3% |
| Pain |
4.3% |
|
| Hallucination, Visual |
28.6% |
| Drug Interaction |
14.3% |
| Malnutrition |
14.3% |
| Musculoskeletal Pain |
14.3% |
| Swelling Face |
14.3% |
| Vomiting |
14.3% |
|
